Accessibility Menu
 
Claritas Pharmaceuticals logo

Claritas Pharmaceuticals

(OTC) CLAZF

Current Price$0.00
Market CapN/A
Since IPO (2017)-100%
5 Year-100%
1 Year+0%
1 Month+0%

Claritas Pharmaceuticals Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

$4.72M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

1087.23 (High)

Price

$0.00

Volume

22,203

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

CLAZF News

No articles available.

CLAZF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Claritas Pharmaceuticals

Industry

Pharmaceuticals

Headquarters

San Rafael, CA 94903, US

CLAZF Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

-99%

Return on Assets

40%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$0.00

Shares Outstanding

0

Volume

22.20K

Short Interest

0.00%

Avg. Volume

363.984

Financials (TTM)

Gross Profit

$0.00

Operating Income

$3.28M

EBITDA

$2.79M

Operating Cash Flow

$309.00K

Capital Expenditure

$0.00

Free Cash Flow

$309.00K

Cash & ST Invst.

$5.00K

Total Debt

$925.00K

Claritas Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2021YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$181.00K

+143.8%

EBITDA

$695.00K

-32.7%

Quarterly Fundamentals

Name
Q3 2021YOY CHG

Net Cash

$546.00K

-34.8%

Accounts Receivable

$102.00K

-38.2%

Inventory

$16.03K

+9814.5%

Long Term Debt

$10.00K

-85.5%

Short Term Debt

$538.00K

-34.9%

Return on Assets

40.31%

N/A

Return on Invested Capital

-98.76%

N/A

Free Cash Flow

$281.00K

-205.2%

Operating Cash Flow

$281.00K

-205.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CKDXFOpthea Limited
$0.44+0.00%
TBGNFOxurion N.V.
$0.17+0.00%
IVEVFInventiva S.A.
$4.44+0.00%
CCHWFColumbia Care Inc.
$0.94-21.71%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About CLAZF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.